Literature DB >> 15354405

Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count.

A Giuliani1, A Caporale, M Corona, M Di Bari, M Demoro, T Ricciardulli, P Gozzo, G Galati, A Tocchi.   

Abstract

To better understand the role of the number of lymph nodes retrieved on long-term outcome of gastric cancer treatment, 154 patients who had undergone curative resection, with dissection of >15 nodes were retrospectively studied. Dissection of perigastric and extraperigastric lymph nodes, defined as 'extended' (>26 nodes dissected) in 39 cases and 'limited' (< or = 26 nodes dissected) in 115 cases, was performed. A total of 3479 lymph nodes (mean 22.6 per specimen), were dissected and of these 721 showed metastases. A mean of 8.1 lymph node metastases, per metastatic case, was found. Regression analysis showed no independent factor associated with the extent of lymphadenectomy. Depth of wall invasion (p=0.000) and histological growth pattern (p=0.044) were independently associated with the number of lymph nodes involved (pN0, pN1 1-7, pN2 >7). The cumulative 5-year survival rate was 47% in patients without lymph node metastases; 29% in those with 1-7 nodes involved and 17% in those with >8 nodes involved (p=0.002). Receiver operating characteristic (ROC) curve analysis, in 65 nodenegative cancer cases, demonstrated an area under the curve for vital status (alive or dead) of 0.602 (95% CI: 0.473 - 0.721). All node-negative cases with a number equivalent to or exceeding the cutoff point of 23 nodes were alive. ROC analysis showed 11 to be the cutoff number of metastasized lymph nodes in correlation with vital status. Almost all those patients in whom the number of positive nodes was equivalent to, or exceeded the cutoff point had died (area under the ROC curve 0.633; 95% CI: 0.524 - 0.733). ROC analysis showed that the cutoff lymph node ratio, in relation to vital status, was 0.33. The majority of patients at or above this cutoff point had died (area under ROC curve 0.682; 95% CI: 0.574 - 0.776). Multivariate survival analysis showed that lymph node ratio was the only independent prognostic factor (p=0.001). The present findings suggest that, in lymphadenectomy with at least 15 nodes, the number and status of regional nodes dissected, irrespective of the location, provide reliable prognostic information on curatively resected gastric carcinomas.

Entities:  

Mesh:

Year:  2004        PMID: 15354405

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  10 in total

1.  Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients.

Authors:  Jian-Wei Su; Ya-Ting Zeng; Shu-Ai Luo; Yu-Ying Sun; Chun-Yu Huang
Journal:  J Oncol       Date:  2022-05-20       Impact factor: 4.501

2.  Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer.

Authors:  Chang-Ming Huang; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Bi-Juan Lin; Hui-Shan Lu
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

3.  Impact of the number of dissected lymph nodes on survival for gastric cancer after distal subtotal gastrectomy.

Authors:  Chang-Ming Huang; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang
Journal:  Gastroenterol Res Pract       Date:  2011-07-24       Impact factor: 2.260

4.  Evaluation of the 7th AJCC TNM Staging System in Point of Lymph Node Classification.

Authors:  Sung Hoo Kim; Tae Kyung Ha; Sung Joon Kwon
Journal:  J Gastric Cancer       Date:  2011-06-30       Impact factor: 3.720

5.  Prognostic factors in patients with node-negative gastric cancer: an Indian experience.

Authors:  Ramakrishnan A Seshadri; Sunil B Jayanand; Rama Ranganathan
Journal:  World J Surg Oncol       Date:  2011-05-10       Impact factor: 2.754

6.  The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer.

Authors:  Wu Song; Yujie Yuan; Liang Wang; Weiling He; Xinhua Zhang; Chuangqi Chen; Changhua Zhang; Shirong Cai; Yulong He
Journal:  Gastroenterol Res Pract       Date:  2014-04-24       Impact factor: 2.260

7.  The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System.

Authors:  Sung Hwan Hwang; Hyun Il Kim; Jun Seong Song; Min Hong Lee; Sung Joon Kwon; Min Gyu Kim
Journal:  J Gastric Cancer       Date:  2016-12-20       Impact factor: 3.720

8.  Clinical Application of Indocyanine Green Fluorescence Technology in Laparoscopic Radical Gastrectomy.

Authors:  Meng Wei; Yize Liang; Limei Wang; Zhen Li; Yuanyuan Chen; Zhibo Yan; Danping Sun; Yadi Huang; Xin Zhong; Peng Liu; Wenbin Yu
Journal:  Front Oncol       Date:  2022-03-04       Impact factor: 6.244

9.  Prognostic value of the lymph node ratio in stage III gastric cancer patients undergoing radical resection.

Authors:  Bin Ke; Xi-Na Song; Ning Liu; Ru-Peng Zhang; Chang-Li Wang; Han Liang
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

10.  Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China.

Authors:  Wei-Han Zhang; Xin-Zu Chen; Kun Yang; Kai Liu; Zhi-Xin Chen; Bo Zhang; Zong-Guang Zhou; Jian-Kun Hu
Journal:  World J Surg Oncol       Date:  2015-12-08       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.